Akums Drugs and Pharmaceuticals IPO GMP Today, Akums Drugs IPO Grey Market Premium Updates |Akums Drugs IPO, Latest target, Opening gain
The company plans to expand its production capacity with two additional production units for its CDMO business to be commissioned in FY 2025. Some of its production facilities have been accredited by various global regulatory bodies such as the European Good Manufacturing Practice (EU-GMP), the World Health Organization Good Manufacturing Practice (WHO-GMP) and the United States National Sanitation Foundation (US NSF).
As of September 30, 2023, Akums Drugs and Pharmaceuticals had a total of 16,463 employees, including 7,211 full-time employees and 9,252 contract employees.
Akums Drugs and Pharmaceuticals IPO Details:
| Issuer | Akums Drugs IPO | |
| Issue Type | Book Built Issue IPO | |
| Issue Period | Issue Opens: 30 July 2024 | |
| Issue Closes: 01 August 2024 | ||
| Price Brand | ₹646 to ₹679 per share | |
| Issue Size | ₹1856.74 Cr | |
| Face Value | ₹2 per share | |
| Market Lot | 22 Shares | |
| Retail (Max) | ₹194,194 | |
| QIB | 75% | |
| HNI | 15% | |
| Retail Individual Bidders | 10% | |
| Listing at | NSE & BSE | |
| ✔️ Apply With | ANGEL Free DEMAT Account | |
| Total Shares | 27,345,162 shares | |
| UPCOMING IPO 2024 | Best sites for stock market |
| Best Stock Trading Apps 2024 | Best book for stock market beginners |
Akums Drugs IPO GMP Rates day by day
Akums Drugs and Pharmaceuticals IPO Market Lot:
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 22 | ₹14,938 |
| Retail (Max) | 13 | 286 | ₹194,194 |
| S-HNI (Min) | 14 | 308 | ₹209,132 |
| S-HNI (Max) | 66 | 1,452 | ₹985,908 |
| B-HNI (Min) | 67 | 1,474 | ₹1,000,846 |
Akums Drugs IPO Date, Allotment & Listing:
| Akums Drugs IPO Opening Date: | JULY 30, 2024 |
| Akums Drugs IPO Closing Date: | AUGUST 01, 2024 |
| Basis of Allotment: | AUGUST 02, 2024 |
| Initiation of Refunds: | AUGUST 05, 2024 |
| Credit to Demat Account: | AUGUST 05, 2024 |
| Listing Date: | AUGUST 06, 2024 |
Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)
Akums Drugs and Pharmaceuticals Limited’s revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 3,516.37 | 3,266.53 | 3,069.05 |
| Revenue | 4,212.21 | 3,700.93 | 3,694.52 |
| Profit After Tax | 0.79 | 97.82 | -250.87 |
| Net Worth | 709.50 | 717.19 | 621.98 |
| Reserves and Surplus | 861.01 | 868.70 | 787.79 |
| Total Borrowing | 491.56 | 536.97 | 357.95 |
| Amount in ₹ Crore | |||
Key Performance Indicator
KPI as of March 31, 2024.
| KPI | Values |
|---|---|
| ROE | 0.11% |
| ROCE | 3.37% |
| Debt/Equity | 0.69 |
| RoNW | -0.57 |
| P/BV | 13.69 |
| PAT Margin (%) | 0.02 |
Objects of the Issue (Akums Drugs and Pharmaceuticals IPO Objectives)
The Company proposes to utilize the Net Proceeds towards the funding of the following objects:
- Repayment/ prepayment of indebtedness of the company and its Subsidiaries;
- Funding incremental working capital requirements of the company;
- Pursuing inorganic growth initiatives through acquisitions; and
- General corporate purposes.
AKUMS DRUGS IPO ALLOTMENT STATUS
How to Apply for Akums Drugs and Pharmaceuticals IPO?
If you’re a new investor Open a DEMAT Account for free with Angel One and build wealth with the best stock choices. Join a 1 million+ family of happy customers.
How to Apply Akums Drugs IPO through Zerodha?
Log in to the Console in the Zerodha Website or Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open a Demat Account with Zerodha.
How to Apply Akums Drugs IPO through Upstox?
Log in to the Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Akums Drugs and Pharmaceuticals”. Click on the Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve – the mandate. Open a Demat Account with Upstox.
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before the UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released after the mandate expiry date.
PARENT COMPANY FOR SHAREHOLDER QUOTA
IPO ALLOTMENT TIPS & TRICKS
Frequently Asked Questions
Akums Drugs and Pharmaceuticals IPO is a main-board initial public offering of 27,345,162 Equity shares of the face value of ₹2 aggregating up to ₹1856.74 Crores. The issue price of the IPO is ₹646 to ₹679 Per Equity Share. The minimum order quantity is 22 Shares per application and the offer type is Book Built Issue. The IPO opens on July 30, 2024 and closes on August 01, 2024. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Akums Drugs IPO opens on July 30, 2024 and closes on August 01, 2024.
You can apply in Akums Drugs and Pharmaceuticals IPO online using either UPI or ASBA as payment method. ICICI Securities Limited, Axis Bank Limited, Citigroup Global Markets India Private Limited and Ambit Private Limited are the book running lead managers of the Akums Drugs and Pharmaceuticals IPO, while Link Intime India Private Ltd is the registrar for the issue.
The finalization of Basis of Allotment for Akums Drugs IPO will be done on August 02, 2024, and the allotted shares will be credited to your demat account by August 05, 2024. Check the Akums Drugs IPO allotment status.
The Akums Drugs IPO listing date is not yet announced. The tentative date of Akums Drugs and Pharmaceuticals IPO listing is August 06, 2024.
Akums Drugs IPO lot size is 22 Shares and the minimum order quantity is 1 Shares.